SCHEMBL17755720

SCHEMBL17755720

O=C(CCc1noc2c1CCCC2)Nc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.48
▸ RAB9A P51151 9/20 0.48
▸ ALDH1A1 P00352 5/20 0.48
▸ LMNA P02545 3/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ SMN1; SMN2 Q16637 7/20 0.47
▸ TP53 P04637 3/20 0.47
▸ GAA P10253 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ HPGD P15428 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ ESR1 P03372 1/20 0.46
▸ NR4A1 P22736 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17755755 0.77 ALDH1A1 (0.47) NPC1RAB9AALDH1A1LMNANPSR1
SCHEMBL17755758 0.77 ALDH1A1 (0.47) NPC1RAB9AALDH1A1LMNANPSR1
SCHEMBL17755760 0.76 ALDH1A1 (0.48) NPC1RAB9AALDH1A1LMNANPSR1
SCHEMBL17755753 0.76 ALDH1A1 (0.48) NPC1RAB9AALDH1A1LMNANPSR1
SCHEMBL17755774 0.74 NPC1 (0.47) NPC1RAB9AALDH1A1LMNANPSR1
SCHEMBL17755719 0.74 HTT (0.53) NPC1RAB9AALDH1A1LMNAMAPT
SCHEMBL3342586 0.67 L3MBTL1 (0.80) ALDH1A1MAPTHTTSMN1; SMN2HPGD
SCHEMBL28427477 0.67 HDAC4 (0.64) ALDH1A1MAPTHTTSMN1; SMN2HPGD
SCHEMBL10745003 0.67 HPGD (0.53) ALDH1A1LMNANPSR1MAPTHTT
SCHEMBL3863186 0.67 MAPT (0.53) NPC1RAB9AMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2016-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF CYP3A7, CYP2C19, CYP3A5 NPC1 1020/4885RAB9A 2602/4885ALDH1A1 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback